Table 3.

Additional annual cost and bed days associated with CHD, ischaemic stroke and TIA in patients with advancing CKD and albuminuria based on KDIGO 2012 criteria in US and UK CKD populations

Colours are based on KDIGO 2102 categories: Green, low risk (if no other markers of kidney disease, no CKD); yellow, moderately increased risk; orange, high risk; red, very high risk. Increase in cost is vs. stage 1 (or without) CKD with normoalbuminuria

KDIGO kidney disease: improving global outcomes, CKD chronic kidney disease